VALIDATION OF EQ-5D AND HADS INDICES TO EVALUATE QUALITY OF LIFE IN PATIENTS WITH PANNICULITIS

Objective: to assess the psychometric properties of EQ-5D and RAPID-3 indices in patients with panniculitis (PN). Subjects and methods. A total of 83 patients (80 women, 3 men) diagnosed with PN, followed up at the V.A. Nasonova Research Institute of Rheumatology in 2013–2015 were examined. The patients’ mean age was 43.4±13.9 years; median disease duration was 5 [2; 24] months. All the patients filled out the EQ-5D and RAPID-3 questionnaires during the first visit and 12 months later. The sensitivity of the questionnaires was assessed by comparing the index scores with the treatment response that was estimated by the achievement of nodular regression at the time of a follow-up examination. The construct validity was determined using a correlation analysis with external criteria. Results and discussion. Positive clinical changes (achievement of nodular regression) were correlated with improvement in EQ-5D and RAPID-3 scores. The median posttreatment change in EQ-5D index scores was 0.27 [0.12; 0.45] (p=0.005), and after treatment the RAPID-3 scores decreased by an average of 9.2±5.2 (p=0.0011). Assessing the validity of EQ-5D index scores in patients with PN revealed moderate correlations not only with clinical (nodular tenderness on palpation, as evaluated by a visual analogue scale, but also with laboratory (erythrocyte sedimentation rate, C-reactive protein levels) parameters. The RAPID-3 function assessment index correlated with the clinical signs of PN. Conclusion. The EQ-5D and RAPID-3 questionnaires are valid and sensitive common instruments for assessing quality of life and functional status in patients with PN.

1. Staquet MJ, Berzon R, Osoba D, et al. Guidelines for reporting results of quality of life assessments in clinical trials. Qual Life Res. 1996 Oct;5(5):496-502. doi: 10.1007/BF00540022

2. World Health Organization. Cancer pain relief. Geneva: WHO; 1986. P. 5-26.

3. Fries JF, Spitz PW, Kraines RG, et al. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23:137-45. doi: 10.1002/art.1780230202

4. The EuroQol group. EuroQol – a new facility for the measurement of health related quality of life. Health Policy. 1990;16(3):199-208.

5. Амирджанова ВН, Эрдес ШФ. Валидация русской версии общего опросника EUROQOL – 5D (EQ-5D). Научно- практическая ревматология. 2007;45(3):69-76 [Amirdzhanova VN, Erdes ShF. Validation of general questionnaire EuroQol-5D (EQ-5D) Russian version. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2007;45(3):69- 76 (In Russ.)]. doi: 10.14412/1995-4484-2007-691

6. Hurst NP, Kind P, Ruta D, et al. Measuring healthrelated quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol. 1997;36:551-9. doi: 10.1093/rheumatology/36.5.551

7. Pincus T, Bergman MJ, Yazici Y. RAPID3 – An index of physical function, pain, and global status as «vital signs» to improve care for people with chronic rheumatic diseases. Bull NYU Hospital Joint Dis. 2009;67(2):211-25.

8. Старкова АС, Амирджанова ВН. Валидация русскоязычной версии опросника RAPID-3. Научно-практическая ревматология. 2011;49(4):36-40 [Starkova AS, Amirdzhanova VN. Validation of the russianlanguage version of the RAPID-3 questionnaire. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2011;49(4):36-40 (In Russ.)]. doi: 10.14412/1995-4484-2011-59

9. Иванов ОЛ. Кожные и венерические болезни. Москва: Шико; 2006. С. 170-4 [Ivanov OL. Kozhnye i venericheskie bolezni [Skin and venereal disease]. Moscow: Shiko; 2006. P. 170-4].

10. Brooks R. EuroQol: The Current State of Play. Health Policy. 1996;37:53-72. doi: 10.1016/0168-8510(96)00822-6

11. Pincus T, Swearingen C, Wolfe F. Toward a multidimensional health assessment questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient friendly health assessment questionnaire format. Arthritis Rheum. 1999;42:2220-30. doi: 10.1002/1529- 0131(199910)42:103.0.CO;2-5

12. Meenan RF, Gertman PM, Mason JH. Measuring helth status in arthritis the Artrithis Impact Measurement Scales. Arthritis Rheum. 1980;23:146-52. doi: 10.1002/art.1780230203

13. Pincus T, Amara I, Segurado O, et al. An index based on only patient reported outcome (PRO) measures, routine assessment of patient index data (RAPID3), distinguishes adalimumab from control at levels similar to disease activity score (DAS28) and clinical disease activity index (CDAI) [Abstract]. Ann Rheum Dis. 2007;184:66.

14. Williamson JW. Evaluating quality of patient care: a strategy relating outcome and process assessment. JAMA. 1971;218(4):564-9. doi: 10.1001/jama.1971.03190170042009

15. Russac SM, Croft JD, Furst DE, et al. The use of Rheumatoid arthritis Health-related quality of life patient questionnaires in clinical practice: lessons learned. Arthritis Care Res. 2003;49(4):574-84. doi: 10.1002/art.11208

16. Борисова ЕВ, Плеханов ИГ, Попов СВ. Качество жизни пациентов после создания полной артриовентрикулярной блокады и имплантации частотно-адаптивного электростимулятора. Сибирский медицинский журнал. 2013;28(2):74-8 [Borisova EV, Plekhanov IG, Popov SV. Quality of life in patients after the creation of artificiak complete atrioventrikuliar heart block and pacemaker implantation. Sibirskiy Meditsinskiy Zhurnal= Siberian Medical Journal. 2013;28(2):74-8 (In Russ.)].

17. Naik H, Howell D, Su S, et al. EQ-5D Health Utility Scores: Data from a Comprehensive Canadian Cancer Centre. Patient. 2017 Feb;10(1):105-15. doi: 10.1007/s40271-016-0190-z

18. Новик АА, Ионова ТИ. Руководство по исследованию качества жизни в медицине. Санкт-Петербург: Олма- Пресс; 2002. 300 с. [Novik AA, Ionova TI. Rukovodstvo po issledovaniyu kachestva zhizni v meditsine [A guide to the study of quality of life in medicine]. St. Petersburg: OLMA-Press; 2002. 300 p.].

19. Насонова ВА. Медицинская и социальная значимость ревматических болезней в России и состояние специализированной помощи. Прогресс в лечении хронических воспалительных заболеваний суставов. Русский медицинский журнал. 2003;(2):4-5 [Nasonova VA. Medical and social significance of rheumatic diseases in Russia and the state of specialized care. Progress in the treatment of chronic inflammatory diseases of the joints. Russkiy Meditsinskiy Zhurnal= Russian Medical Journal. 2003;(2):4-5 (In Russ.)].